Cell-penetrating peptides (CPPs) have attracted increasing attention in the past decade as a result of their high potential to convey various, otherwise impermeable, bioactive agents across cellular plasma membranes. Albeit different CPPs have proven potent in delivery of different cargoes, there is generally a correlation between high efficacy and cytotoxicity for these peptides. Hence, it is of great importance to find new, non-toxic CPPs with more widespread delivery properties. We present a novel CPP, M918, that efficiently translocates various cells in a non-toxic fashion. In line with most other CPPs, the peptide is internalized mainly via endocytosis, and in particular macropinocytosis, but independent of glycosaminoglycans on the ce...
Within this study, we report about the design and biological characterization of novel cell-penetrat...
AbstractUnique characteristics, such as nontoxicity and rapid cellular internalization, allow the ce...
A major obstacle in the development of new therapeutic agents is the low bioavailability of hydrophi...
The plasma membrane functions as a barrier, restricting entry of hydrophilic pharmaceutical agents. ...
The hydrophobic plasma membrane constitutes an indispensable barrier for cells in living animals. Al...
Cell-penetrating peptides (CPPs) have emerged as a group of remarkable delivery vectors for various ...
The hydrophilic nature of peptides and proteins renders them impermeable to cell membranes. Thus, in...
International audienceThe recent discovery of new potent therapeutic molecules that do not reach the...
The cell membrane is a highly selective barrier. This limits the cellular uptake of molecules includ...
Cell-penetrating peptides (CPPs) have for a little bit more than a decade been employed as delivery ...
Therapeutic cargos which are impermeable to the cell can be delivered by cell penetrating peptides (...
The plasma membrane is a large barrier to systemic drug delivery into cells, and it limits the effic...
Cellular and nuclear delivery of biomolecules is limited by low membrane permeability. Cell-penetrat...
AbstractThe recent discovery of new potent therapeutic molecules that do not reach the clinic due to...
Cell-penetrating peptides (CPPs), also known as protein transduction domains, are a class of diverse...
Within this study, we report about the design and biological characterization of novel cell-penetrat...
AbstractUnique characteristics, such as nontoxicity and rapid cellular internalization, allow the ce...
A major obstacle in the development of new therapeutic agents is the low bioavailability of hydrophi...
The plasma membrane functions as a barrier, restricting entry of hydrophilic pharmaceutical agents. ...
The hydrophobic plasma membrane constitutes an indispensable barrier for cells in living animals. Al...
Cell-penetrating peptides (CPPs) have emerged as a group of remarkable delivery vectors for various ...
The hydrophilic nature of peptides and proteins renders them impermeable to cell membranes. Thus, in...
International audienceThe recent discovery of new potent therapeutic molecules that do not reach the...
The cell membrane is a highly selective barrier. This limits the cellular uptake of molecules includ...
Cell-penetrating peptides (CPPs) have for a little bit more than a decade been employed as delivery ...
Therapeutic cargos which are impermeable to the cell can be delivered by cell penetrating peptides (...
The plasma membrane is a large barrier to systemic drug delivery into cells, and it limits the effic...
Cellular and nuclear delivery of biomolecules is limited by low membrane permeability. Cell-penetrat...
AbstractThe recent discovery of new potent therapeutic molecules that do not reach the clinic due to...
Cell-penetrating peptides (CPPs), also known as protein transduction domains, are a class of diverse...
Within this study, we report about the design and biological characterization of novel cell-penetrat...
AbstractUnique characteristics, such as nontoxicity and rapid cellular internalization, allow the ce...
A major obstacle in the development of new therapeutic agents is the low bioavailability of hydrophi...